Search

everythinglearnresearchcommunity

for

Search:↓

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

Testosterone replacement is recommended for men with low testosterone levels and symptoms of hypogonadism.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Natural small molecules can help treat diseases by activating or inhibiting the Wnt pathway.

A new method accurately measures nine specific hormones in human blood.

Horse skin stem cells combined with platelet-rich plasma improve skin healing.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Indian dermatologists recommend treating common hair loss with a balanced diet, stress reduction, mild shampoos, and sometimes minoxidil and supplements.

The review concluded that reporting on PRP therapy is often incomplete, leading to uncertainty about its effectiveness.

Platelet-rich plasma shows potential for hair loss and skin rejuvenation but needs more research for widespread use.

The treatment improved hair growth in three patients with alopecia.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

All five human steroid 5α-reductase enzymes are found in the endoplasmic reticulum.

Generic drug inserts in Saudi Arabia often have inaccurate information, needing better regulation and quality control.

High mTORC1 activity slows hair growth and causes it to lose color.

Men in the U.S. have more health issues, higher death rates from various diseases, lower life expectancy, and are less likely to seek healthcare.

A new treatment for hair loss was tested and most participants saw their hair loss stop within 2-8 weeks, with up to 50% more hair after 4 months, and no side effects.

Topical finasteride is an effective and safer treatment for male hair loss.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.